IMUX (immunic-therapeutics.com) Sof foyda

IMUX (immunic-therapeutics.com) - kompaniyaning tovar belgisi

Immunic, Inc. (IMUX) sklerozning tarqoq shakliga qarshi kurashish uchun selektiv oral agentlarning global darajada joriy etilishiga e'tibor qaratadi. Kompaniyaning umumiy foydasi pul oqimi dinamikasini aks ettiradi, bunda -0.11 ushbu parametrning miqdorini belgilaydi. Biznes samaradorligi biomateriallarning AQSh va Yevropadagi tibbiyot markazlariga operatsion yetkazib berilishiga bog'liq, sotuvlar salohiyati esa surunkli yallig'lanishning xavfsiz terapiyasiga bo'lgan yuqori talab bilan qo'llab-quvvatlanadi.

IMUX (Immunic, Inc.) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

immunic-therapeutics.com (IMUX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Immunic|IMUX - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi IMUX|IMUX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Immunic|IMUX - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi immunic-therapeutics.com|IMUX - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Immunic, Inc.|IMUX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Immunic|IMUX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar IMUX|IMUX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Immunic|Shoshilinch likvidlik immunic-therapeutics.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
IMUX - Sof foyda
Kompaniyaning jamlanma tahlili:Immunic, Inc.
Immunic Therapeutics asosiy tovari

Immunic, Inc. (IMUX) kredit sifatini baholash uchun tahlilchi barcha xarajatlar va soliqlarni chegirib tashlagandan keyingi yakuniy moliyaviy natijani aks ettiruvchi sof foydani ko'rib chiqadi. Foyda tendentsiyasi kompaniyaning sklerozning ko'p oqimli shakllari uchun oral terapiya vositalarini ishlab chiqishni monetizatsiya qilish qobiliyatini namoyish etadi, bunda yuqoriga yo'nalgan egri chiziq klinik sinovlarning tijorat muvaffaqiyatini tasdiqlaydi, mahalliy cho'qqilar esa aktiv uchun kirish risklaridan signal beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Sof moliyaviy natija Pharming Corp PHAR|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|Sof daromad upstreambio.com|Kompaniyaning sof foydasi Zenas Biopharma|Sof daromad Immunome Inc (IMNM)|Sof daromad GOSS (Gossamer Corp)|Sof foyda KalVista Corp (KALV)|Kompaniyaning sof foydasi Septerna Inc SEPN|PVLA: Kompaniya foydasi|Savara - Sof foyda|Sof moliyaviy natija Rigel Pharma RIGL|ANAB: Sof foyda|Sof daromad Astria Corp|Sof daromad ENGN|RAPT: Yakuniy foyda|Sof foyda JBIO|Sof moliyaviy natija Aclaris Therapeutics Inc.|Kompaniyaning sof foydasi Kyverna KYTX|TLSA: Kompaniya foydasi|Cabaletta Bio, Inc. - Sof foyda|ventyxbio.com (VTYX) - Sof daromad|THTX (Theratechnologies) - Sof daromad|AVTX - Sof moliyaviy natija|ELDN (Eledon) - Sof foyda|Agenus, Inc (AGEN) - Sof moliyaviy natija|Kompaniyaning sof foydasi Climb Bio Inc (CLYM)|Sof daromad zurabio.com ZURA|aTyr Pharma - Sof daromad|Sof foyda Adagene Inc ADAG|IMA: Sof daromad|STTK (Shattuck Labs, Inc.) - Kompaniya foydasi|equilliumbio.com (EQ) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda CNTB (Connect Biopharma Holdings Limited)|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|IFRX: Yakuniy foyda|Sof foyda XFOR|Sof foyda adicetbio.com (ACET)|Kompaniyaning sof foydasi Celularity CELU|Yakuniy foyda INMB|BRNS - Kompaniyaning sof foydasi|Kezar Life Sciences Inc. (KZR) - Sof daromad|SABS: Sof foyda|Akari Therapeutics, Plc (AKTX) - Sof foyda|Sof daromad ENLV|QTTB: Yakuniy foyda|Sof foyda GOVX|Sof moliyaviy natija Edesa Biotech Inc|Kompaniyaning sof foydasi iBio Corp IBIO|CARM - Sof daromad|XTLB - Kompaniyaning sof foydasi|Bolt Biotherapeutics (BOLT) - Sof daromad|HCWB (hcwbiologics.com) - Sof daromad|Aptevo Therapeutics Inc. (APVO) - Sof foyda|Kompaniyaning sof foydasi AIM ImmunoTech|Kompaniya foydasi ADTX (Aditxt Corp)|Sof foyda GRI|XRTX - Kompaniyaning sof daromadi|Sof foyda HIND (Vyome Holdings)|Sof moliyaviy natija Revelation Biosciences Inc (REVB)|INDP - Kompaniyaning sof foydasi|BiondVax Pharmaceuticals (SCNI) - Sof daromad|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|Sof daromad ALLK|Sof foyda HOOKIPA|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|iTeos Pharma - Kompaniya foydasi|Sof foyda OCEA (Ocean Biomedical, Inc.)|Sof moliyaviy natija tcbiopharm.com (TCBP)|Third Harmonic Bio, Inc. - Sof foyda